CD3 antibody and IL-2 complex combination therapy inhibits atherosclerosis by augmenting a regulatory immune response.

Journal of the American Heart Association

Volumn 3, Issue 2, 2014, Pages

  Kasahara, Kazuyuki ^a   Sasaki, Naoto ^b   Yamashita, Tomoya ^b   Kita, Tomoyuki ^b   Yodoi, Keiko ^b   Sasaki, Yoshihiro ^b   Takeda, Masafumi ^b   Hirata, Ken Ichi ^b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; APOLIPOPROTEIN E; CD3 ANTIGEN; INTERLEUKIN 2; MONOCLONAL ANTIBODY;

ANIMAL; ANTIGEN ANTIBODY COMPLEX; AORTA; AORTA DISEASE; ARTICLE; ATHEROSCLEROSIS; CELLULAR IMMUNITY; CHOLESTEROL INTAKE; DISEASE MODEL; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; GENETICS; HELPER CELL; IMMUNE SYSTEM; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; PATHOLOGY; PHENOTYPE; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE;

ATHEROSCLEROSIS; IMMUNE SYSTEM; INFLAMMATION; T CELL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, CD3; AORTA; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL, DIETARY; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; IMMUNITY, CELLULAR; INTERLEUKIN-2; MACROPHAGES; MICE; MICE, KNOCKOUT; PHENOTYPE; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 84904606235     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.113.000719     Document Type: Article

References (0)